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Here we describe a simple, single-tube T7 RNA polymerasebased linear DNA amplification method ( Fig. 1a and Supplementary Fig. 1 ), termed linear DNA amplification (LinDA), for transcription factor ChIP-seq with as little as 30 pg DNA. Although the fidelity and nonbiased nature of T7 RNA polymerase-based amplification has been demonstrated 9, 11, 12 , the products of these reactions cannot be directly used for highthroughput sequencing. Furthermore, the complex handling steps of these protocols are incompatible with ultra-small amounts of DNA. Therefore, our T7 RNA polymerase-based protocol uses a single buffer during amplification. Consecutive steps are performed in the same tube, thus eliminating the need for column purification and minimizing the risk of sample losses. Note that this feature makes this protocol suited for process automation.
When developing LinDA, we compared three modifications of the original T7 RNA polymerase linear amplification protocol 9, 12 ( Supplementary Fig. 2a) . We obtained the highest amplification by LinDA (Supplementary Fig. 2b ), which combined critical modifications of the other protocols, namely buffer and enzyme optimization and introduction of a 3′ inverse T7 primer in the RNA. The use of primer adapters consisting of a T7 promoter and an oligo(dA) sequence for double-strand synthesis regenerated a DNA with T7 primers for the next round of amplification. To optimize the amplified DNA for sequencing, we ultimately used a T7 promoter-BpmI-oligo(dA) primer adaptor, which facilitated removal of the T7 promoter and 16 additional oligo(dA) nucleotides.
To validate LinDA, we amplified a 404-base-pair (bp) luciferase gene (Luc) fragment. Using LinDA, we generated the predicted 527-bp DNA, and sequencing confirmed the presence of the T7 promoter at both ends (Supplementary Fig. 2c ). To quantify LinDA in presence of a large excess of heterologous genomic DNA, we spiked 100 ng of sheared salmon sperm DNA with various amounts of Luc DNA. Quantitative PCR (qPCR) analysis revealed a highly reliable 300-fold amplification over 3 logs of the spiked luciferase DNA concentrations (Supplementary Fig. 2d ).
To determine whether LinDA can be used to reliably amplify ChIPed DNA, we compared estrogen-induced target gene-binding of estrogen receptor α (ERα) by qPCR analysis of nine different target loci, which had been identified in a separate ChIP-seq study 13 using H3396 human breast cancer cells. The fold induction of ERα occupancy at these sites (relative to the 'silent' locus DPP10) was virtually indistinguishable when we compared 3 ng of ChIPed DNA with a 30 pg aliquot prepared by LinDA (Fig. 1b) . High-throughput sequencing, coupled with conventional chromatin immunoprecipitation (ChIP) provides a genome-wide view of chromatin modification and dynamics and reveals the action of transcription-modulating complexes. It is now possible to investigate (epigenetic) transcription control programs, which regulate phenomena ranging from stemness to cell homeostasis, differentiation and senescence. Although these technologies are widely applied, the need to recover nanogram amounts of immunoprecipitated DNA is a serious limitation. This concerns particularly small compartments of major (patho)physiological importance, such as stem cells, cancer-initiating cells or groups of cells specifying development and organogenesis. ChIP studies of chromatin histone modifications for small cell numbers have been described [1] [2] [3] , but the techniques are incompatible with high-throughput sequencing. It is therefore necessary to preamplify DNA enriched in ChIP experiments ('ChIPed DNA') before sequencing. DNA-amplification protocols have been reported 4, 5 , but multiple ligations and exponential PCR amplification make them prone to the introduction of artifacts and amplification bias [6] [7] [8] [9] . Also, a recent protocol for ChIP-seq for profiling modified histones from about 10,000 cells involves 15 plus 18 cycles of PCR 10 . Compared to ChIP with antibodies to histones, ChIP with antibodies to transcription factors yield much less immunoprecipitated DNA. To date, no versatile technique has been described that (i) demonstrates reliable amplification of picogram DNA quantities of complex DNA samples corresponding (Fig. 1c) , thus revealing similar rates of amplification. LinDA can be used efficiently with the standard ChIP protocol if antibody amounts are adjusted. We performed ChIP-seq of ERα with as few as 5,000 cells, identifying about 70% of the high-confidence peaks, and globally profiled histone H3 Lys4 trimethylation (H3K4me3) with 10,000 cells (Fig. 1d, Supplementary Fig. 3a,b and Supplementary Table 1) . Modifications of the LinDA-ChIPseq protocol and increasing sequencing depths are likely to reduce the number of cells required for global profiling below 1,000 cells. Notably, in contrast to PCR-based techniques, LinDA shows no G+C amplification bias (Supplementary Fig. 3c) .
We next compared profiles generated by Illumina sequencing from 3.5 ng of an RXRα-specific ChIP from F9 cells (RXRα(1)), a biological replicate done at a different time (RXRα(2)) and a LinDA-generated library from 35 pg of RXRα(1) (Supplementary Table 1 ). Statistically significant binding sites in RXRα(1) and the corresponding LinDA-ChIP-seq were annotated by model-based analysis of ChIP-seq data (MACS) 14 using 10 −5 as P-value cutoff.
Comparison of MACS-annotated regions as described previsously 10 in the context of their read-count intensities in 1-kb windows surrounding MACS-annotated peaks using seqMINER 15 , revealed a Pearson correlation coefficient of 0.89 (Fig. 1e) . Visual comparison of the ChIP-seq profiles confirmed excellent concordance ( Fig. 1f and Supplementary Fig. 4 ). Although this correlation was comforting, the binning approach may be suboptimal for transcription factors, which bind to short, well-defined sequences, as the resulting cohort may be dominated by peaks with low tag counts or low P values. We therefore established receiver operating characteristics curves by defining the overlaps between MACS-predicted peaks at different P values. Our goal was to define the P value at which 100% of the LinDA peaks were detected in ChIP-seq data of nonamplified DNA. This analysis showed that all LinDA peaks were detected in the ChIP-seq of the original sample at P < 10 −9 for RXRα(1) and 10 −10 for the independent replicate RXRα(2). At these P values about half of the RXRα peaks were detected by LinDA (Supplementary Fig. 5a,b) . Clustering of the top 200 sites revealed that LinDA-ChIP-seq results corresponded to those for a biological replicate and detected with similar efficiency sites harboring RXR family response elements (Supplementary Fig. 6 ). Together these data show that LinDA permitted 100% reliable retrieval of genomewide transcription factor binding sites from picogram amounts of ChIPed DNA. Using longer reads and increasing the number of (mappable) reads, the sensitivity of LinDA is likely to increase.
Although ChIP-seq analyses reveal global binding of a transcription factor, these factors frequently act in concert with others. Often transcription factors function as heterodimers, like the RXR family, or they are members of high-molecular-weight complexes, or they bind to targets cooperatively with other factors. Analysis of joint binding is therefore of importance to reveal subprograms linked to a particular transcription factor complex or modification 13 . One possibility to study cooperative chromatin binding genome-wide is the use of reChIP, which involves a second immunoprecipitation performed on the first ChIP products with a different antibody. However, reChIPs yield very small amounts of DNA, and the first ChIP has to be done with a huge amount of cells, which is costly and time-consuming. (1) and RXRα (2) as well as the corresponding LinDA-ChIP-seq profile of an equal amount of 100-fold-diluted RXRα(1). In d and f, the x axis gives RefSeq gene annotation.
To assess the utility of LinDA for reChIPs, we defined the bindingsite repertoire of the RXRα-RARγ heterodimer relative to the global binding patterns of RXRα and RARγ in F9 cells 2 h after ATRA-induced differentiation. We reChIPed RXRα ChIPed chromatin with antibodies to RARγ. As the immunoprecipitated DNA could not be quantified by a method with a detection limit of 100 pg, we subjected half of it to LinDA, yielding 30 ng DNA. Using onehalf of the nonamplified reChIP material, we compared the ATRAinduced binding to four known ATRA-responsive loci with the LinDA-reChIP, revealing comparable ATRA-induced occupancy of RXRα-RARγ (Fig. 2a) . Notably, sequencing of the LinDA-amplified reChIP (Supplementary Table 1 ) yielded 3,683 MACS-predicted peaks (P = 10 −5 ) of which 2,277 overlapped with the cohorts of peaks obtained by separate ChIP-seq analysis of RXRα and RARγ (Fig. 2b) . Visual inspection of LinDA-reChIP profiles with the separate ChIPseq analyses of RXRα and RARγ showed high concordance (Fig. 2c) . Sites outside the 2,277 cohort most likely correspond to binding of RXRα heterodimers with RARα or RARβ and of RARγ heterodimers with RXRβ or RXRγ. Indeed, such sites were not retrieved by LinDA-reChIP-seq (Fig. 2d,e) , thus revealing the heterodimer selectivity of the approach. Note the potential of this assay for the analysis of joint binding of different factors to a common site or the subunit identification of a heterodimer at a chromatin target.
Improvements of the ChIP procedure, increases in sequencing depth and addition of more round(s) of LinDA are likely to permit such assays for (a few) hundred cells. LinDA will also facilitate chromatin conformation capture-based technologies for the mapping of long-range interaction. Although LinDA can be used to amplify any source of DNA, it will be particularly useful to analyze transcription factor complexes, histone modification and chromatin remodeling in very small compartments, such as stem and cancer-initiating cells. 
